The disintegration of normal behaviour by cancer calls also manifests itself into altered metabolism through unbalanced fluxes through metabolic pathways. The identity of the molecular mechanisms behind these changes are still enigmatic.
It is, however, evident that if we can harness the insight into the dysfunctional metabolic balances, it can potentially equip us with a new weapon in the arsenal for treating and curing cancer patients.
Member of the steering committee
Paolo Ceppi
Studies how metabolism affects cancer differentiation and sensitivity to chemotherapy
Member of the steering committee
Kumar Sumyajit
Exposes the molecular details of DNA replication, cell cycling, and DNA repair